Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

RAISR4D Suicide

Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

BMJ. 2025 Apr 28;389:r845. doi: 10.1136/bmj.r845.

NO ABSTRACT

PMID:40294951 | DOI:10.1136/bmj.r845

Document this CPD

AI-assisted Evidence Research

Share Evidence Blueprint

QR Code

Search Google Scholar

RAISR4D Evidence Matrix

InPsychiatry, RAISR4D

Latest Evidence

Follow @Psychiatryaicom WhatsApp Psychiatry AI

Recent Post

The Julian Assange case and its implications for expert witness evidence

Cognitive behavioural therapy for intolerance of uncertainty: A study protocol for the prevention of postpartum anxiety

Association of gender-based discrimination and burnout among faculty in an urban academic medical center

Psychiatric Manifestations in Polycythemia Vera: A Case of Refractory Delirium and Psychosis Responding to Hematological Treatment

Relationships among cortical activation, cognition, and blood biomarkers in two types of dementia determined using functional near-infrared spectroscopy

Top Category

ChatGPT

Enter your request.

← The roles of adverse childhood experiences and genetic liability in risk for suicidal thoughts and behaviors: A factor analytic approach ← Impact of the expanded old age income security programme on suicide mortality among older adults in South Korea: a quasi-experimental study